MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression

In Vivo

Volumn 16, Issue 6, 2002, Pages 583-588

  Bodey, Bela ^a,c   Siegel, Stuart E ^a,c   Kaiser, Hans E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Intl Soc Stud Compar Oncol   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Astrocytoma (ASTR); Cancer testis antigen (CTA); Glioblastoma multiforme; Immunophenotype (IP); Melanoma associated CT gene (MAGE); Monoclonal antibody (MoAB); Neoplasm associated antigen (NAA); Neoplasm associated marker (NAM)

Indexed keywords

ALKALINE PHOSPHATASE; BIOTIN; FORMALDEHYDE; HORMONE; IMMUNOGLOBULIN; MELANOMA ANTIGEN 1; MONOCLONAL ANTIBODY; PARAFFIN; PROTEIN; STREPTAVIDIN; TESTICULAR PROTEIN; TUMOR ANTIGEN; TUMOR TESTIS ANTIGEN; UNCLASSIFIED DRUG; MAGEA1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; CANCER CELL; CANCER GENETICS; CANCER GRADING; CANCER GROWTH; CHILD; CHILDHOOD CANCER; CONJUGATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENOME; GERM CELL; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MELANOMA; MICROENVIRONMENT; MITOSIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPERMATOCYTE; SPERMATOGONIUM; STAINING; STATISTICAL SIGNIFICANCE; BIOSYNTHESIS; BRAIN TUMOR; CELL COUNT; CLASSIFICATION; DISEASE COURSE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ASTROCYTOMA; BRAIN NEOPLASMS; CELL COUNT; CHILD; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036861316     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kun LE: Brain tumors: Challenges and directions. Pediatr Clin North Am 44: 907-917, 1997.
2. Cairncross JG: The biology of astrocytoma: Lessons learned from chronic myelogenous leukemia-hypothesis. J Neuro-Oncol 5: 99-104, 1987.
3. Greaves M, Janossy G, Francis G and Minowada J: Membrane phenotypes of human leukemic cells and leukemic cell lines: Clinical correlates and biological implications. In: B Clarkson, PL Marks, and J Till (eds), Differentiation of Normal and Neoplastic Hemopoietic Cells, Vol 5, pp 823-841, Cold Spring Harbor Conferences on Cell Proliferation, Cold Spring Harbor Laboratory, New York, 1977.
4. Burns BF: Molecular genetic markers in lymphoproliferative disorders. Clin Biochem 22: 33-39, 1989.
5. Bodey B, Zeltzer PM, Saldivar V and Kemshead J: Immunophenotyping of childhood astrocytomas with a library of monoclonal antibodies. Int J Cancer 45: 1079-1087, 1990.
6. Ohgaki K, Schäuble B, Zur Hausen A, Von Ammon K and Kleihues P: Genetic alterations associated with the evolution and progression of astrocytic brain tumors. Virchows Arch 427: 113-118, 1995.
7. Ma Z, Khatlani TS, Li L, Sasaki K, Okuda M, Inokuma H and Onishi T: Molecular cloning and expression analysis of feline melanoma antigen (MAGE) obtained from a lymphoma cell line. Vet Immunol Immunopathol 83: 241-252, 2001.
8. Weiser TS, Ohnmacht GA, Guo ZS, Fischette MR, Chen GA, Hong JA, Nguyen DM and Schrump DS: Induction of MAGE-3 expression in lung and esophageal cancer cells. Ann Thorac Surg 71: 295-301; discussion 301-302, 2001.
9. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61: 5544-5551, 2001.
10. Ohman Forslund K and Nordqvist K: The melanoma antigen genes - Any clues to their functions in normal tissues? Exp Cell Res 265: 185-194, 2001.
11. Van Der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van Den Eynde B, Knuth A and Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991.
12. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, Van Der Bruggen P, Lethe B, Lurquin C et al.: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369, 1994.
13. Rogner UC, Wilke K, Steck E, Korn B and Poutska A: The melanoma antigen (MAGE) family is clustered in the chromosomal band Xq28. Genomics 29: 725-731, 1995.
14. Lurquin C, De Smet C, Brasseur F, Muscatelli F, Marterlange V, De Plaen E, Brasseur R, Monaco AP and Boon T: Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46: 397-408, 1997.
15. Lucas S, De Smet C, Arden KC, Viars CS, Lethe B, Lurquin C and Boon T: Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 58: 743-752, 1998.
16. Pold M, Zhou J, Chen GL, Hall JM, Vescio RA and Berenson JR: Identification of a new, unorthodox member of the MAGE gene family. Genomics 59: 161-167, 1999.
17. Aubry F, Satie AP, Rioux-Leclercq N, Rajpert-De Meyts E, Spagnoli GC, Chomez P, De Backer O, Jegou B and Samson M: MAGE-A4,a germ cell specific marker, is expressed differentially in testicular tumors. Cancer 92: 2778-2785, 2001.
18. Gillespie AM and Coleman RE: The potential of melanoma antigen expression in cancer therapy. Cancer Treat Rev 25: 219-227, 1999.
19. Chen Y-T and Old LJ: Cancer-testis antigens: Targets for cancer immunotherapy. Cancer J from Scientific American 5: 16-17, 1999.
20. Marchand M, Van Baren N, Weymans P, Brichard V, Dreno B, Tessier MH, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, Lienard D, Beauduin M, Dietrich PY, Russo V, Kerger J, Masucci G, Jager E, De Greve J, Atzpodien J, Brasseur F, Coulie PG, Van Der Bruggen P and Boon T: Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 80: 219-230, 1999.
21. Boon T and Old LJ: Tumor antigens. Curr Opin Immunol 9: 681-683, 1997.
22. Sahin U, Koslowski M, Tureci O, Eberle T, Zwick C, Romeike B, Moringlane JR, Schwechheimer K, Feiden W, Pfreunschuh M: Expression of cancer testis genes in human brain tumors. Clin Cancer Res 6: 3916-3922, 2000.
23. Zulch KJ and Wechsler W: Pathology and classification of gliomas. Progr Neurol Surg, vol. 2, Karger, Basel-New York, pp 1-84, 1968.
24. Zulch KJ. Histologic classification of tumours of the central nervous system. International Histological Classification of Tumours, No. 21, World Health Organization, Geneva, 1979.
25. Zulch KJ: Principles of the new World Health Organization (WHO) classification of brain tumors. Neuroradiology 19: 59-66, 1980.
26. Szymas J: Histologic classification of central nervous system tumors by the World Health Organization. Pol J Pathol 45: 81-91, 1994.
27. Szymas J: Diagnostic immunohistochemistry of tumors of the central nervous system. Folia Neuropathol 32: 209-214, 1994.
28. Bodey B, Bodey B Jr, Sigel SE and Kaiser HE: Immunocytochemical detection of the honebox B3, B4 and C6 gene products in Childhood medulloblastomas/primitive neuroectodermal tumors. Anticancer Res 20: 1769-1780, 2000.
29. Shi S-R, Key ME and Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
30. Shi S-R, Cote C, Kalra KL, Taylor CR and Tandon AK: A technique for retrieving antigens in formalin-fixed, routinely acid-decalcified, celloidin-embedded human temporal bone sections for immunohistochemistry. J Histochem Cytochem 40: 787-792, 1992.
31. Key ME, Shi S-R and Kalra KL: Antigen retrieval in formalin-fixed tissues using microwave energy. US Patent # 5,244,787; 14 September 1993.
32. Beckstead JH: Improved antigen retrieval in formalin-fixed, paraffinn-embedded tissues. Appl Immunohistochem 2: 274-281, 1994.
33. Cuevas EC, Bateman AC, Wilkins BS, Johnson PA, Williams JH, Lee AH, Jones DB and Wright DH: Microwave antigen retrieval in immunohistochemistry: A study of 80 antibodies. J Clin Pathol 47: 448-452, 1994.
34. Chen T, Zhang D, Shi S.-R and Taylor CR: Antigen retrieval pretreatment: Microwaving procedures and alternative heating methods. BioLink 4: 2, 1995.
35. Janckila AJ, Yam LT and Li C.-Y: Immunoalkaline phosphatase cytochemistry. Am J Clin Pathol 84: 476-480, 1985.
36. Cattoretti G, Berti E, Schiro R, D'Amato L, Valeggio C and Rilke F: Improved avidin-biotin-peroxidase complex (ABC) staining. Histol J 20: 75-80, 1988.
37. Yam LT, Janckila AJ, Epremian BE and Li C.-Y: Diagnostic significance of levamisole-resistant alkaline phosphatase in cytochemistry and immmunocytochemistry. Am J Clin Pathol 91: 31-36, 1989.
38. Strasburger CJ, Amir-Zaltsman Y and Kohen F: The avidin-biotin reaction as an universal amplification system in immunoassays. Prog Clin Biol Res 285: 79-100, 1988.
39. Wilchek M and Bayer EA: Introduction to avidin-biotin technology. Methods Enzymol 184: 5-13, 1990.
40. Duhamel RC and Whitehead JS: Prevention oof nonspecific binding of avidin. Methods Enzymol 184: 201-207, 1990.
41. Diamandis EP and Christopoulos TK: The biotin-(strept)avidin system: Principles and applications in biotechnology. Clin Chem 37: 625-636, 1991.
42. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison of ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 29: 577-581, 1981.
43. Shi S-R, Key ME and Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
44. Shi S-R, Cote C, Kalra KL, Taylor CR and Tandon AK: A technique for retrieving antigens in formalin-fixed, routinely acid-decalcified, celloidin-embedded human temporal bone sections for immunohistochemistry. J Histochem Cytochem 40: 787-792, 1992.
45. Beckstead JH: Improved antigen retrieval in formalin-fixed, paraffin-embedded tissues. Appl Immunohistochem 2: 274-281, 1994.
46. Chen T, Zhang D, Shi S.-R and Taylor CR: Antigen retrieval pretreatment: Microwaving procedures and alternative heating methods. BioLink 4: 2, 1995.
47. Shi SR, Cote RJ and Taylor CR: Antigen retrieval techniques: Current perspectives J Histochem Cytochem 49: 931-937, 2001.
48. Shi SR, Cote RJ and Taylor CR: Antigen retrieval immunohistochemistry: Past, present and future. J Histochem Cytochem 45: 327-343, 1997.
49. Battifora H: The multitumor (sausage) tissue block: Novel method for immunohistochemical antibody testing. Lab Invest 55: 244-248, 1986.
50. Battifora H and Mehta P: The checkerboard tissue block. An improved multitissue control block. Lab Invest 63: 722-724, 1990.
51. Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, Hong WK and Mao L: Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 61: 7959-7963, 2001.
52. Eifuku R, Takenoyama M, Yoshino I, Imahayashi S, So T, Yasuda M, Sugaya M and Yasumoto K: Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes. Int J Clin Oncol 6: 34-39, 2001.
53. Haffner AC, Tassis A, Zepter K, Storz M, Tureci O, Burg G and Nestle FO: Expression of cancer/testis antigens in cutaneous T cell lymphomas. Int J Cancer 97: 668-670, 2002.
54. Mashino K, Sadanaga N, Tanaka F, Yamaguchi H, Nagashima H, Inoue H, Sugimachi K and Mori M: Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Br J Cancer 85: 713-720, 2001.
55. Bodey B: Cancer-testis antigens: Promising targets for antigen directed antineoplastic immunotherapy. Expert Opinion Biological Therapy 2: 577-584, 2002.